Spinal Cord Stimulation for the Treatment of Vascular Pathology

Neurosurgery Clinics of North America

Volumn 25, Issue 1, 2014, Pages 25-31

  Deogaonkar, Milind ^a   Zibly, Zion ^a   Slavin, Konstantin V ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Critical limb ischemia; Peripheral arterial disease; Peripheral vascular disease; Spinal cord stimulation; Spinal neuromodulation

Indexed keywords

NITRIC OXIDE; PROSTAGLANDIN;

BLOOD VESSEL TONE; CLAUDICATION; CRITICAL LIMB ISCHEMIA; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; HUMAN; LIMB SALVAGE; NEUROMODULATION; NEUROPATHIC PAIN; PATIENT SELECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; QUALITY OF LIFE; REVIEW; SPINAL CORD STIMULATION; SURVIVAL RATE; SYMPATHETIC FUNCTION; TREATMENT OUTCOME;

CRITICAL LIMB ISCHEMIA; PERIPHERAL ARTERIAL DISEASE; PERIPHERAL VASCULAR DISEASE; SPINAL CORD STIMULATION; SPINAL NEUROMODULATION;

HUMANS; PAIN MANAGEMENT; PERIPHERAL VASCULAR DISEASES; SPINAL CORD STIMULATION;

EID: 84887994007     PISSN: 10423680     EISSN: 15581349     Source Type: Journal    
DOI: 10.1016/j.nec.2013.08.013     Document Type: Review

References (35)

1. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
2. Newman A.B., Shemanski L., Manolio T.A., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999, 19:538-545.
3. Murabito J.M., Evans J.C., Nieto K., et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002, 143:961-965.
4. Creager M.A., Luscher T.F., Cosentino F., et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003, 108:1527-1532.
5. Luscher T.F., Creager M.A., Beckman J.A., et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Circulation 2003, 108:1655-1661.
6. White C. Clinical practice. Intermittent claudication. NEngl J Med 2007, 356:1241-1250.
7. De Vries J., De Jongste M.J., Spincemaille G., et al. Spinal cord stimulation for ischemic heart disease and peripheral vascular disease. Adv Tech Stand Neurosurg 2007, 32:63-89.
8. Amann W., Berg P., Gersbach P., et al. Spinal cord stimulation in the treatment of non-reconstructable stable critical leg ischaemia: results of the European Peripheral Vascular Disease Outcome Study (SCS-EPOS). Eur J Vasc Endovasc Surg 2003, 26:280-286.
9. Melzack R., Wall P.D. Pain mechanisms: a new theory. Science 1965, 150:971-979.
10. Cook A.W. Epidural stimulation for vascular disease of extremities. JNeurosurg 1981, 55:664.
11. Cook A.W., Oygar A., Baggenstos P., et al. Vascular disease of extremities. Electric stimulation of spinal cord and posterior roots. NY State J Med 1976, 76:366-368.
12. Jivegard L.E., Augustinsson L.E., Holm J., et al. Effects of spinal cord stimulation (SCS) in patients with inoperable severe lower limb ischaemia: a prospective randomised controlled study. Eur J Vasc Endovasc Surg 1995, 9:421-425.
13. Tallis R.C., Illis L.S., Sedgwick E.M., et al. Spinal cord stimulation in peripheral vascular disease. JNeurol Neurosurg Psychiatry 1983, 46:478-484.
14. Reig E., Abejon D. Spinal cord stimulation: a 20-year retrospective analysis in 260 patients. Neuromodulation 2009, 12:232-239.
15. Brummer U., Condini V., Cappelli P., et al. Spinal cord stimulation in hemodialysis patients with critical lower-limb ischemia. Am J Kidney Dis 2006, 47:842-847.
16. Ubbink D.T., Spincemaille G.H., Prins M.H., et al. Microcirculatory investigations to determine the effect of spinal cord stimulation for critical leg ischemia: the Dutch multicenter randomized controlled trial. JVasc Surg 1999, 30:236-244.
17. Kumar K., Toth C., Nath R.K., et al. Improvement of limb circulation in peripheral vascular disease using epidural spinal cord stimulation: a prospective study. JNeurosurg 1997, 86:662-669.
18. Horsch S., Schulte S., Hess S. Spinal cord stimulation in the treatment of peripheral vascular disease: results of a single-center study of 258 patients. Angiology 2004, 55:111-118.
19. Ubbink D.T., Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev 2013, (2). CD004001.
20. Naoum J.J., Arbid E.J. Spinal cord stimulation for chronic limb ischemia. Methodist Debakey Cardiovasc J 2013, 9:99-102.
21. Pedrini L., Magnoni F. Spinal cord stimulation for lower limb ischemic pain treatment. Interact Cardiovasc Thorac Surg 2007, 6:495-500.
22. Tanaka S., Komori N., Barron K.W., et al. Mechanisms of sustained cutaneous vasodilation induced by spinal cord stimulation. Auton Neurosci 2004, 114:55-60.
23. Tanaka S., Barron K.W., Chandler M.J., et al. Local cooling alters neural mechanisms producing changes in peripheral blood flow by spinal cord stimulation. Auton Neurosci 2003, 104:117-127.
24. Tanaka S., Barron K.W., Chandler M.J., et al. Role of primary afferents in spinal cord stimulation-induced vasodilation: characterization of fiber types. Brain Res 2003, 959:191-198.
25. Provenzano D.A., Nicholson L., Jarzabek G., et al. Spinal cord stimulation utilization to treat the microcirculatory vascular insufficiency and ulcers associated with scleroderma: a case report and review of the literature. Pain Med 2011, 12:1331-1335.
26. Provenzano D.A., Jarzabek G., Georgevich P. The utilization of transcutaneous oxygen pressures to guide decision-making for spinal cord stimulation implantation for inoperable peripheral vascular disease: a report of two cases. Pain Physician 2008, 11:909-916.
27. Deer T.R., Raso L.J. Spinal cord stimulation for refractory angina pectoris and peripheral vascular disease. Pain Physician 2006, 9:347-352.
28. Reig E., Abejon D., del Pozo C., et al. Spinal cord stimulation in peripheral vascular disease: a retrospective analysis of 95 cases. Pain Pract 2001, 1:324-331.
29. Wu M., Linderoth B., Foreman R.D. Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies. Auton Neurosci 2008, 138:9-23.
30. Klomp H.M., Spincemaille G.H., Steyerberg E.W., et al. Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study Group. Lancet 1999, 353:1040-1044.
31. Claeys L.G., Horsch S. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation. Int Angiol 1996, 15:344-349.
32. Petrakis E., Sciacca V. Prospective study of transcutaneous oxygen tension (TcPO2) measurement in the testing period of spinal cord stimulation in diabetic patients with critical lower limb ischaemia. Int Angiol 2000, 19:18-25.
33. Babu R., Hazzard M.A., Huang K.T., et al. Outcomes of percutaneous and paddle lead implantation for spinal cord stimulation: a comparative analysis of complications, reoperation rates, and health-care costs. Neuromodulation 2013, 10.1111/ner.12065.
34. Huang K.T., Hazzard M.A., Babu R., et al. Insurance disparities in the outcomes of spinal cord stimulation surgery. Neuromodulation 2013, 10.1111/ner.12059.
35. Kinfe T.M., Schu S., Quack F.J., et al. Percutaneous implanted paddle lead for spinal cord stimulation: technical considerations and long-term follow-up. Neuromodulation 2012, 15:402-407.